Catalio Capital Management, LP 13F Portfolio
| Entity | Category | QoQ AUM Change | AUM (13F) | # of Holdings | Performance Rank | Equities Trend |
|---|---|---|---|---|---|---|
CC Catalio Capital Management, LP | Institutional Filer | ▼ 15.39% | $478.7M | 41 |
Current Portfolio Holdings
Showing all 41 reported positions by value
| # | Stock | Company Name | Sector | Shares Held | Market Value | % of Portfolio |
|---|---|---|---|---|---|---|
| 1 | DNTH | Dianthus Therapeutics, Inc. | Healthcare | 560K | $47.0M | 9.82% |
| 2 | BBIO | BridgeBio Pharma, Inc. | Healthcare | 432K | $32.1M | 6.70% |
| 3 | ASND | Ascendis Pharma A/S | Healthcare | 129K | $29.5M | 6.17% |
| 4 | BMY | Bristol-Myers Squibb Company | Healthcare | 421K | $25.5M | 5.33% |
| 5 | SNDX | Syndax Pharmaceuticals, Inc. | Healthcare | 1.0M | $24.4M | 5.09% |
| 6 | GILD | Gilead Sciences, Inc. | Healthcare | 164K | $22.8M | 4.77% |
| 7 | TERN | Terns Pharmaceuticals, Inc. | Healthcare | 409K | $21.6M | 4.50% |
| 8 | DFTX | DEFINIUM THERAPEUTICS INC | — | 1.0M | $19.6M | 4.10% |
| 9 | SLNO | Soleno Therapeutics, Inc. | Healthcare | 578K | $19.3M | 4.04% |
| 10 | BSX | Boston Scientific Corporation | Healthcare | 299K | $18.8M | 3.92% |
| 11 | RARE | Ultragenyx Pharmaceutical Inc. | Healthcare | 851K | $17.8M | 3.72% |
| 12 | INCY | Incyte Corporation | Healthcare | 182K | $17.1M | 3.58% |
| 13 | CYTK | Cytokinetics, Incorporated | Healthcare | 216K | $14.2M | 2.97% |
| 14 | NTRA | Natera, Inc. | Healthcare | 71K | $14.2M | 2.96% |
| 15 | CRVS | Corvus Pharmaceuticals, Inc. | Healthcare | 892K | $13.0M | 2.73% |
Showing 1 to 15 of 41 holdings